Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 942-422-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://chesar.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1978
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Pre-GLP study following a method equivalent to a recognised guideline
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 978
- Report date:
- 1978
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Principles of method if other than guideline:
- Method employed in this study for the detection of delayed contact hypersensitivity was the guinea-pig maximization test described by B. Magnusson and A.M. Kligman (1970) in "Allergic Contact Dermatitis in the Guinea-Pig: Identification of contact allergens"; C.C. Thomas, USA.
- GLP compliance:
- no
- Remarks:
- In accordance with REACH Regulation (EC) 1907/2006: Annex XI: section 1.1.2 adequate and reliable (with restrictions) study information has been provided (not in accordance with GLP) but which can be considered equivalent to the relevant test method.
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- In accordance with REACH Regulation (EC) 1907/2006: Annex VII: column 2 as amended by Commission Regulation (EU) 2017/706, a well documented study report conducted before 10 May 2017, following a method equivalent or similar to guideline with acceptable deviations is available. This is sufficient to fulfil the standard information requirement in accordance with REACH Regulation (EC) 1907/2006: Annex XI: section 1.1.2 since adequate and reliable (with restrictions) study information has been provided suitable for classification and labelling and/or risk assessment.
Test material
- Reference substance name:
- Reaction products of ((5E)-5-ethylidenebicyclo[2.2.1]hept-2-ene and (5Z)-5-ethylidenebicyclo[2.2.1]hept-2-ene) and 2-methyl-1,3-butadiene, epoxidized
- EC Number:
- 942-422-6
- Molecular formula:
- Not applicable (a generic molecular formula cannot be provided for this specific UVCB substance)
- IUPAC Name:
- Reaction products of ((5E)-5-ethylidenebicyclo[2.2.1]hept-2-ene and (5Z)-5-ethylidenebicyclo[2.2.1]hept-2-ene) and 2-methyl-1,3-butadiene, epoxidized
- Test material form:
- other: liquid
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Recognised supplier
- Housing: Throughout the investigation the guinea-pigs were housed in a suspended cage with a wire mesh floor.
- Diet (e.g. ad libitum): vitamin-C enriched guinea pig pelleted diet ad libitum; hay once per week
- Water (e.g. ad libitum): tap water ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): Not reported
- Humidity (%): Not reported
- Air changes (per hr): Not reported.
- Photoperiod (hrs dark / hrs light): Not reported
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- other: dipropylene glycol (DIPG) (10%) aqueous
- Concentration / amount:
- Preliminary irritation testing: intradermal: 1% (maximum non-irritating dose) ; topical: 100% (undiluted)
Induction:
- Intradermal: 1% test material
- Topical: 100% test material (undiluted)
- Challenge: 25%
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: dipropylene glycol (DIPG) (10%) aqueous
- Concentration / amount:
- Preliminary irritation testing: intradermal: 1% (maximum non-irritating dose) ; topical: 100% (undiluted)
Induction:
- Intradermal: 1% test material
- Topical: 100% test material (undiluted)
- Challenge: 25%
- No. of animals per dose:
- Test group: 10
- Details on study design:
- RANGE FINDING TESTS:
Preliminary Investigations: The intradermal and topical irritancy of a range of dilutions of the test substance was investigated. The maximum concentration suitable for intradermal injection was found to be 1% v/v in 10% aqueous dipropylene glycol (DIPG), and for topical application to be undiluted test substance. These concentrations were subsequently utilised in the induction phase of the main study. A sub-erythemal concentration of test substance 25% v/v in DIPG was selected for the challenge application.
MAIN STUDY
A. INDUCTION EXPOSURE
Intradermal induction: intradermal injections of a 1% v/v mixture of the test substance in 10% aqueous DIPG, a 1% v/v mixture of the test substance 10% aqueous DIPG 50:50 with Complete Freund's Adjuvant, and 50% aqueous Complete Freund's Adjuvant alone into the shaved 4x6 cm dorsal area of each of 10 guinea pigs.
Topical Application: Seven days after intradermal injections, the topical induction phase was conducted. Prior to the topical induction, the 4x6cm injection sites were clipped free of hair. A volume of 0.4 ml of undiluted test substance was spread over a 3 x 6 cm patch of Whatman No.3 MM paper. The patch was placed on the skin and covered by a 6 cm length of impermeable plastic adhesive tape (4 cm width "Blenderm"). This in turn was firmly secured by elastic adhesive bandage ("Elastoplast" 6.4 cm width) wound round the torso. The dressing was left in place for 48 hours.
B. CHALLENGE EXPOSURE
14 days after the induction period, Hair was removed with electric clippers from a 5 x 5 cm area on the left flank of each guinea pig. The test sample (0.1 ml) was applied to a 2 x 2 cm Whatman No, 3 MM paper in a similar fashion to that used for topical induction application. The patch was sealed to the flank for 24 hours under o 4 cm strip of "Blenderm" covered by "Elastoplast" wound round the trunk and secured with "Sleek" impervious plastic adhesive tape. The challenge site was evaluated 24, 48 end 72 hours after removal of the patch. The scoring system for responses was fully described within the study report. - Positive control substance(s):
- no
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- 1 test animal died prior to challenge; death was not considered as test substance related
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 25%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: 1 test animal died prior to challenge; death was not considered as test substance related.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- 1 test animal died prior to challenge
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 25%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: 1 test animal died prior to challenge.
- Reading:
- other: 3rd reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- 1 test animal died prior to challenge
- Remarks on result:
- other: Reading: other: 3rd reading. . Hours after challenge: 72.0. Group: test group. Dose level: 25%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: 1 test animal died prior to challenge.
Any other information on results incl. tables
Table 1. Dermal reactions elicited in challenge application
No. |
E/O scores |
24 hours |
48 hours |
72 hours |
Results (positive or negative) |
1 |
E O |
0 0 |
0 0 |
0 0 |
- |
2 |
E O |
0 0 |
0 0 |
0 0 |
- |
3 |
E O |
* |
* |
* |
N/A |
4 |
E O |
0 0 |
0 0 |
0 0 |
- |
5 |
E O |
0 0 |
0 0 |
0 0 |
- |
6 |
E O |
0 0 |
0 0 |
0 0 |
- |
7 |
E O |
0 0 |
0 0 |
0 0 |
- |
8 |
E O |
0 0 |
0 0 |
0 0 |
- |
9 |
E O |
0 0 |
0 0 |
0 0 |
- |
10 |
E O |
0 0 |
0 0 |
0 0 |
- |
* died prior to challenge; reported as not test substance related
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Remarks:
- EU criteria not met
- Conclusions:
- Under the conditions of this study used, the test material is not considered to be a contact sensitizer.
- Executive summary:
The study was performed according to a method equivalent to guideline OECD TG 406 consistent with Magnusson-Kligman maximisation test to assess the skin sensitisation potential of the test substance. The study was conducted using a preliminary irritation screen, a two-stage induction phase and a challenge phase. Preliminary irritation testing was for use in the induction phases of the study and the challenge phase of the study. The first stage of the induction phase involved intradermal injections of a 1% v/v mixture of the test substance in 10% aqueous DIPG, a 1% v/v mixture of the test substance 10% aqueous DIPG 50:50 with Complete Freund's Adjuvant, and 50% aqueous Complete Freund's Adjuvant alone into the dorsal area of each of 10 guinea pigs. After 7 days the second stage of the induction phase entailed the topical application of the undiluted test substance onto the shaved dorsal area of the test group animals using occlusive dressings for 48 hours. 14 days after the induction period, a challenge dose of the test substance 25% v/v in DIPG was selected for the challenge application to the left flank on each test animal using the same procedure as in the topical induction. The site was inspected at 24, 48 and 72 hours for the presence of erythema and oedema. Under the conditions of this study, the test material is not considered to be a contact skin sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)